Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Buy

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Neutral

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Buy

A

Dyadic International, Inc. (DYAI)

Biological Products, (no Disgnostic Substances)

https://www.dyadic.com

Dyadic International Inc is a global biotechnology platform company. The company has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins, and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

1044 NORTH U.S. HIGHWAY ONE, SUITE 201
JUPITER, FL

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

11/05/2004

Market Cap

37,144,724

Shares Outstanding

28,810,000

Weighted SO

28,811,061

Total Employees

N/A

Upcoming Earnings

08/14/2024

Similar Tickers

HOWL --.--%

EWTX --.--%

DBTX --.--%

CELC --.--%

CCCC --.--%

ANEB --.--%

PMVP --.--%

ANTX --.--%

ELYM --.--%

Beta

0.7280

Last Div

0.0000

Range

1.13-2.67

Chg

-0.0599

Avg Vol

109979

Mkt Cap

37144724

Exch

NASDAQ

Country

US

Phone

561 743 8333

DCF Diff

0.6533

DCF

2.4033

Div Yield

0.0000

P/S

20.5890

EV Multiple

-4.5587

P/FV

11.6502

Div Yield %

0.0000

P/E

-4.7682

PEG

-0.2882

Payout

0.0000

Current Ratio

5.3901

Quick Ratio

5.3901

Cash Ratio

3.1477

DSO

56.2370

DIO

0.0000

Op Cycle

56.2370

DPO

82.7025

CCC

-26.4655

Gross Margin

0.5001

Op Margin

-4.4613

Pretax Margin

-4.2907

Net Margin

-4.2907

Eff Tax Rate

0.3010

ROA

-0.7282

ROE

-1.4595

ROCE

-0.9271

NI/EBT

1.0000

EBT/EBIT

0.9618

EBIT/Rev

-4.4613

Debt Ratio

0.5176

D/E

1.7367

LT Debt/Cap

0.6324

Total Debt/Cap

0.6346

Int Coverage

-7.7549

CF/Debt

-1.0837

Equity Multi

3.3554

Rec Turnover

6.4904

Pay Turnover

4.4134

Inv Turnover

0.0000

FA Turnover

15.3743

Asset Turnover

0.1697

OCF/Share

-0.2036

FCF/Share

-0.2036

Cash/Share

0.3447

OCF/Sales

-3.3049

FCF/OCF

1.0000

CF Coverage

-1.0837

ST Coverage

-116.7392

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

11.6502

P/B

11.6502

P/S

20.5890

P/E

-4.7682

P/FCF

-6.2298

P/OCF

-6.1904

P/CF

-6.1904

PEG

-0.2882

P/S

20.5890

EV Multiple

-4.5587

P/FV

11.6502

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jan 02, 08:30 Dyadic to Attend J.P. Morgan 42nd Annual Healthcare Conference GlobeNewswire Inc. Nov 30, 08:30 Dyadic Attends Investor Events in December GlobeNewswire Inc. Nov 20, 08:30 Dyadic’s C1 Platform to be Used to Produce Vaccines for Humans and Animals in Africa

Revenue Product Segmentation